Diphtheria, Tetanus, and Acellular Pertussis (Tdap) Vaccine (Boostrix)

Vaccine (active immunizing agent, combined diphtheria-tetanus-acellular pertussis)

Diphtheria, Tetanus, and Acellular Pertussis (Tdap) Vaccine (Boostrix)

Forms and strengths
Form: TabletStrength: Not less than 2 IU diphtheria toxoid, 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg filamentous hemagglutinin, and 2.5 mcg pertactin per 0.5 mL dose
Print

Indication

  • This vaccine is used as a booster against diphtheria, tetanus, and pertussis in individuals from 4 years of age onward; it is not intended for a primary immunization series.
  • This vaccine is used during pregnancy to provide passive protection against pertussis in early infancy, through antibodies passed from the mother to the baby.
  • Booster doses against diphtheria and tetanus are generally recommended at 10-year intervals, or sooner for wound management in certain circumstances.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.